Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Liver Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07177742
What this trial is testing

Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis

Who this might be right for
Colorectal CancerLiver Metastases From Colorectal CancerPathology+2 more
Mu-qing Yang 260
Early research (Phase 1)Study completedNCT06184841
What this trial is testing

HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma

Who this might be right for
Hepatic Arterial Infusion ChemotherapyLiver MetastasesEsophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 25
Not applicableStudy completedNCT07386639
What this trial is testing

Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver CancerNeoplasm Metastasis
Tongji University 19,019
Testing effectiveness (Phase 2)Looking for participantsNCT06690528
What this trial is testing

Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver

Who this might be right for
Pancreatic Cancer Metastatic
Azienda Ospedaliera di Padova 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07815288
What this trial is testing

Retlirafusp Alfa Plus Targeted Therapy and Chemotherapy for Unresectable Colorectal Liver-Limited Metastases

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the Liver
Peking University Cancer Hospital & Institute 80
Early research (Phase 1)Looking for participantsNCT07197554
What this trial is testing

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid TumorsEwing SarcomaHepatocellular Carcinoma (HCC)+1 more
SEED Therapeutics, Inc. 171
Testing effectiveness (Phase 2)UnknownNCT01949194
What this trial is testing

Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers

Who this might be right for
Metastatic Colorectal Cancer
Gerald Batist 48
Testing effectiveness (Phase 2)Study completedNCT02063529
What this trial is testing

FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 101
Not applicableUnknownNCT03881501
What this trial is testing

Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Huazhong University of Science and Technology 2
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00273312
What this trial is testing

Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 25
Large-scale testing (Phase 3)Looking for participantsNCT06371157
What this trial is testing

AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Akeso 469
Not applicableStudy completedNCT02692365
What this trial is testing

Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI

Who this might be right for
Primary or Metastatic Tumor in the Liver Parenchyma
Hospital Sirio-Libanes 20
Not applicableActive Not RecruitingNCT03408665
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

Who this might be right for
Liver CancerLiver Metastases
Centre Oscar Lambret 280
Not applicableStudy completedNCT00414492
What this trial is testing

Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 100
Testing effectiveness (Phase 2)Looking for participantsNCT06978933
What this trial is testing

FGF19 Overexpression Combination Unified Study in HCC-19

Who this might be right for
HCC - Hepatocellular Carcinoma
RenJi Hospital 42
Post-approval studies (Phase 4)WithdrawnNCT00510627
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Who this might be right for
Metastatic Liver CancerSecondary Liver CancerLiver Neoplasm
Boston Scientific Corporation
Testing effectiveness (Phase 2)Study completedNCT00700570
What this trial is testing

Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Study completedNCT01967823
What this trial is testing

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

Who this might be right for
MelanomaMeningiomaBreast Cancer+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Next Page